Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...

CSL’s balance sheet is in sound condition. Financial risk is low given low revenue cyclicality and product demand is being largely driven by chronic indications. We forecast CSL’s net debt to EBITDA ...

The glycosylation of protein ... Fc fragment of the antibody varies greatly between different cultured cells and different batches (Brantley et al., 2021). Recombinant antibodies have two clearance ...

SARS-CoV-2 binds to the human cell receptor angiotensin-converting enzyme 2 ... Inc. Tainan, Taiwan. C-terminal Fc-tagged human ACE2 recombinant protein (ACE2-hFc) was purified from CHO cells (Cat. No ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

These findings are of important clinical relevance, as the therapeutic potential of transmembrane activator and cyclophilin ligand interactor-Fc (atacicept ... The cDNA encoding soluble extracellular ...